ACOUSORT AB

History

Year	Detail
2010	AcouSort AB was established to commercialize the research activities in Lund, Sweden.
2014	AcouSort AB developed the AcouTrap, a benchtop research instrument used to prepare samples of cells, extracellular vesicles, and bacteria from various media.
2016	AcouSort AB was transformed from a project-based company to a completely operational organization.
2017	AcouSort AB received its first commercial order from the American Institute of Health (NIH) to provide a prototype of the AcouWash system.
2019	AcouSort AB received $4,47,790 in funding from Vinnova through Eurostars for the project AcouPlast. AcouPlast aims to manufacture polymer acoustofluidic chips for high-performing, fast, and cost-effective plasma separation, allowing healthcare and veterinary Point-of-Care (PoC) diagnostics.
2021	AcouSort AB launched AcouWash 2, the new version of the company’s cell washing and separation system. The system and its applications will be presented in two presentations at µTAS.
2022	AcouSort AB accelerated its commercial focus on targeting the cell therapy market.
2023	The European Innovation Council (EIC) funded the AcouSome project 100% with $2.7 million over 36 months.